3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever The notification of regaining compliance is a positive development for Gain Therapeutics ...

Gain Therapeutics (GANX) announced the presentation of a poster at the 36th EORTC-NCI-AACR, ENA, Symposium on molecular targets and cancer ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

BETHESDA, Md., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a ...

With a gain of more than 531% over the last 12 months, shares of Viking Therapeutics (NASDAQ: VKTX) are a hot commodity, to ...

Viking Therapeutics (NASDAQ: VKTX) soared to center stage earlier this year as a potentially promising player in one of today ...

On Monday, C4 Therapeutics Inc (CCCC) stock saw a modest uptick, ending the day at $6.45 which represents a slight increase of $0.84 or 14.97% from the prior close of $5.61. The stock opened at $5.58 ...

Analyst David Martin PhD of Bloom Burton maintained a Buy rating on Knight Therapeutics (KHTRF – Research Report), with a price target of ...

On Thursday, Karyopharm Therapeutics Inc (KPTI) stock saw a modest uptick, ending the day at $0.99 which represents a slight increase of $0.15 or 17.86% from the prior close of $0.84. The stock opened ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

BETHESDA, MD – Gain Therapeutics, Inc. (NASDAQ:GANX), a biopharmaceutical company, announced today that it has regained compliance with Nasdaq's minimum Market Value of Listed Securities (MVLS) ...